Pharmacists in Albuquerque, New Mexico
1112 Pharmacists found in Albuquerque
Dr. Jc Thomas Lovelace, RPH
Pharmacist
111 Coors Blvd Nw, Albuquerque, NM 87121
505-836-5322 505-839-4454
Jean Ann Graham, RPH
Pharmacist
500 Walter St Ne, Suite 201, Albuquerque, NM 87102
505-727-2900 505-727-2990
Jeanette Danielle Lovato, PHARM. D.
Pharmacist
2121 Juan Tabo Blvd Ne, Albuquerque, NM 87112
505-237-8850
Ms. Jeanice M Weber, PHARMD
Pharmacist
5901 Harper Dr Ne, Albuquerque, NM 87109
505-823-8552 505-823-8591
Jeanie E Goodrich, RPH
Pharmacist
200a Tramway Blvd Se, Albuquerque, NM 87123
505-301-1027 505-822-1889
Mrs. Jeanne Cecile Basile, RPH, PHC
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
10701 Lomas Blvd Ne, Suite 210-b, Albuquerque, NM 87112
505-803-8010 505-796-8290
Dr. Jeffrey Coleman Larsen, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1131 University Blvd Ne, Suite G, Albuquerque, NM 87102
505-272-2341
Dr. Jeffrey Jay Fisher, PHARM.D.
Pharmacist - Pharmacotherapy
1501 San Pedro Dr Se, Albuquerque, NM 87108
505-265-1711
Jeffrey P Norenberg, RPH
Pharmacist - Nuclear
8513 Canyon Run Rd Ne, Albuquerque, NM 87111
505-463-1894
Jenifer Weese, PHARM D
Pharmacist
4700 Cutler Ave Ne, Albuquerque, NM 87110
505-346-1661 505-346-0703
Mrs. Jenna Domzalski De Rios, PHARMD
Pharmacist
2105 Central Ave Nw, Albuquerque, NM 87104
505-242-2713
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.